In Hong Kong, ParC changes among high-level quinolone-resistant Neisseria gonorrhoeae (QRNG) isolates at Ser-873Arg were associated with a higher level of resistance than a Ser-873Ile alteration. Two previously undescribed mutations in clinical isolates occurring in gyrA, conferring Ala-923Pro and Asp-953Tyr changes, were detected. Nine different outer membrane lipoprotein (Lip) repeat classes-11 to 19 repeats-were identified, with repeat lengths of 16 and 17 the most common, indicating considerable strain diversity.
In Hong Kong, a dramatic increase in quinolone-resistant Neisseria gonorrhoeae (QRNG) isolates has been observed (2) (3) (4) . These made up 24% of our isolates in 1996 and 50% of our isolates in 1998 and then reached a high level of endemicity of 80% in 2000. All N. gonorrhoeae isolates possess an outer membrane lipoprotein, designated Lip, which was first revealed by a monoclonal antibody designated H.8. The protein epitope is immunogenic in humans and conserved among pathogenic Neisseria species, including N. gonorrhoeae and N. meningitidis, but not most nonpathogenic Neisseria species. We report on the current genetic alteration patterns within the quinolone resistance-determining region (QRDR) in GyrA and ParC proteins from organisms with various levels of quinolone resistance in Hong Kong and also examined these strains by Lip subtyping (1) and assessed whether Lip subtyping is useful in a situation in which QRNG isolates are occurring at high levels of endemicity.
One hundred six clinical strains of N. gonorrhoeae were drawn randomly from isolates obtained consecutively from patients attending government sexually transmitted disease (STD) clinics during the year 2001. These strains were tested by a standard methodology (5) and classified into four categories of ofloxacin susceptibilities: (i) MIC of Ն8 g/ml, 27 isolates; (ii) MIC of Ն2 but Յ4 g/ml, 45 isolates; (iii) MIC of Ն0.125 but Ͻ2 g/ml, 28 isolates; and (iv) MIC of Ͻ0.125 g/ml, 6 isolates. These were grouped according to previously published data, which correlated MIC with treatment outcome (4). Four World Health Organization (WHO) quality assurance strains (GC1, GC4, GC5, and 94G395) and two controls (F28 and F45) from the Centers for Disease Control and Prevention (CDC), Atlanta, Ga., were used because the ofloxacin MICs for these strains are known, although their molecular characters have not been previously described.
The amino acid substitutions in GyrA or ParC protein, based on the nucleotide sequences of gyrA and parC gene fragments that include QRDRs of the respective proteins were investigated by methods previously described (8) (9) (10) . Nucleotide sequencing was performed by a D-rhodamine dideoxynucleotide chain termination method by using the ABI PRISM 310 Genetic Analyzer (Perkin-Elmer, Foster City, Calif.). Sequence compilation and analyses were carried out with DNAstar software programs (DNASTAR, Inc., Madison, Wis.). For alignment, gyrA and parC genes were compared with U08817 and U08907, respectively (T. Deguchi, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Kawada, T. Ezaki, and I. Saito, Letter, Antimicrob. Agents Chemother. 40:2437-2438, 1996). The lip gene was amplified by PCR after extraction of the chromosomal DNA by DNAzol (Molecular Research Center, Inc., Cincinnati, Ohio). Amplicons were sequenced, and the primers were used as described previously (12) . Profiles of known Liptype patterns, kindly supplied by D. L. Trees (STD Branch, CDC), were used for alignment and analysis.
Forty-nine percent of patients acquired the strains locally, while the source of contact of the other patients could be traced to other Chinese provinces, including Macau, in 47% of our isolates. A minority of patients originated from the Philippines and Pakistan, which together accounted for 2%, while the source of the remaining 2% was unknown.
Out of 100 isolates, the ofloxacin MIC for 28 isolates was Ն0.125 g/ml but Յ1 g/ml, while the ofloxacin MICs for 17, 28, 14, and 13 isolates were 2, 4, 8, and Ն16 g/ml, respectively. Table 1 shows the frequency distribution of various GyrA/ParC alteration patterns of quinolone-resistant strains against the respective ofloxacin MICs. Isolates for which the ofloxacin MIC was Ͼ0.06 but Յ1 g/ml had 11 patterns, mainly possessing a single-site alteration in GyrA (64%). Simultaneous mutations at single sites in both gyrA and parC were mainly found in this category. In contrast, isolates for which the ofloxacin MICs ranged from 2 to Ն16 g/ml did not possess alterations at a single site in QRDR. They had double and triple mutations in both gyrA and parC. Isolates for which the ofloxacin MIC was Ͼ1 g/ml had 18 patterns, and 2 patterns predominated-GyrA (Ser913Phe, Asp953Gly) with ParC (Ser873Arg) and GyrA (Ser913Phe, Asp953Gly) with ParC() (where ⌽ represents the QRDR without mutation)-both in ParC, accounting for 24 and 21%, respectively. Isolates with higher-level resistance (MIC of Ն4 g/ml) had an increased tendency toward three mutations in gyrA and parC (P Ͻ 0.01). The Ser-873Arg alteration in ParC was associated with a higher level of resistance (MIC of Ն8 g/ml) (P Ͻ 0.001). Two isolates containing the Ser-873Ile substitution displayed the same high level of resistance (MIC of Ն16 g/ ml). Two new mutations among clinical isolates occurring in gyrA, conferring an Ala-923Pro change (MIC ϭ 2 g/ml) and Asp-953Tyr (MIC ϭ 4 g/ml) were detected. Double alterations in both GyrA and ParC were not found, although they have been reported elsewhere (6, 7, 10) . Substitutions in parC alone were not found.
Among the 106 quinolone-susceptible and -resistant isolates, 9 different Lip repeat classes were identified, ranging from 11 to 19 repeats, but repeat length 20 was not found (12) . The respective ofloxacin susceptibility categories [i.e., (i) MIC of Ͻ0.125 g/ml, (ii) MIC of Ն0.125 but Ͻ4 g/ml, and (iii) MIC of Ն4 g/ml] belonged to four (13 to 16 repeats), seven (12 to 18 repeats), and nine (11 to 19 repeats) Lip repeat classes, respectively. Repeat lengths of 16 and 17 were the most predominant in the current sample, comprising 23.6 and 25.5%, respectively. Even though they were predominant, they were found distributed in all ofloxacin MIC categories (except for the group for which an ofloxacin MIC was Ͻ0.125 g/ml) as well as with the MICs of the other antibiotics tested, including penicillin, tetracycline, erythromycin, spectinomycin, and ceftriaxone (data not shown). After sequencing, the number of 
Ser91 3 Phe and Asp95 3 Gly Asp86 3 Asn Ͼ8 (94G395) Ser91 3 Phe and Asp95 3 Gly Glu91 3 Gly a ⌽ represents QRDR without mutation. GC1, GC4, GC5, and 94G395 were QAP strains from WHO, while F28 and F45 were strains from CDC. Based on the sequence differences in the repeats that resulted in amino acid alterations, the nine repeat patterns could be further classified into 28 subtypes. There were three subtypes in the proportion of 13:11:1 in the 16-repeat class and three subtypes in the proportion of 25:1:1 in the 17-repeat class as shown in Table 4 . Repeat classes 11 and 19 had a low occurrence, and it is probable that these are more conserved during the course of evolution of quinolone resistance, although there is no genetic linkage between lip, gyrA, and parC.
A variety of QRDR patterns were present in Hong Kong, and the most prevalent ones were GyrA (Ser913Phe, Asp953 Gly) with ParC (Ser873Arg) (25%) and GyrA (Ser913Phe, Asp953Gly) with ParC () (21%) in ParC. In a recent report, the former alteration pattern was also present in a single strain isolated from mainland China (6) . Further studies will be needed to compare cross-country differences, as well as longitudinal changes, in QRDR patterns among QRNG strains isolated from different localities in the region.
Silent mutations in codons 104 (TAT to TAC), 129 (GCG to GCA), and 131 (CTC to CTG) of parC genes were detected. The former two did not occur in the absence of the latter. These silent mutations occurred in 75% of QRNG strains, but there was no association between these mutations and the alterations in QRDR of GyrA and ParC.
The ParC alterations reported to date have occurred in amino acids Gly-85, Asp-86, Ser-87, Ser-88, Glu-91, Ala-92, and Arg-116 (8, 10) . The Asp863Asn alteration was the most prominent pattern seen in the Philippines (11) . Ser883Pro was more commonly found in Japan (8, 9) , while Ser873Ile, which confers high-level resistance (MIC of Ն16 g/ml), was reported in Hawaii, the Philippines, and Japan (11, 13; Deguchi et al., Letter). In Hong Kong, since ofloxacin had been used as the first-line drug for a long period of time, and given the large numbers of travelers passing through from other countries, we have now seen the emergence of a wide variety of alterations in N. gonorrhoeae, and types have been identified that are different from those previously described.
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